State Street’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-28,779
| Closed | -$503K | – | 4000 |
|
|
2020
Q4 | $503K | Sell |
28,779
-2,439
| -8% | -$34.2K | ﹤0.01% | 3645 |
|
|
2020
Q3 | $365K | Sell |
31,218
-4,780
| -13% | -$63.4K | ﹤0.01% | 3608 |
|
|
2020
Q2 | $468K | Sell |
35,998
-2,610
| -7% | -$31.4K | ﹤0.01% | 3548 |
|
|
2020
Q1 | $358K | Buy |
38,608
+3,758
| +11% | +$52.5K | ﹤0.01% | 3504 |
|
|
2019
Q4 | $579K | Buy |
34,850
+2,320
| +7% | +$37.6K | ﹤0.01% | 3498 |
|
|
2019
Q3 | $541K | Buy |
32,530
+1,620
| +5% | +$22.4K | ﹤0.01% | 3495 |
|
|
2019
Q2 | $425K | Sell |
30,910
-408,856
| -93% | -$6.25M | ﹤0.01% | 3531 |
|
|
2019
Q1 | $7.58M | Buy |
439,766
+22,474
| +5% | +$356K | ﹤0.01% | 2582 |
|
|
2018
Q4 | $5.33M | Sell |
417,292
-124
| -0% | -$1.88K | ﹤0.01% | 2681 |
|
|
2018
Q3 | $6.78M | Buy |
417,416
+4,656
| +1% | +$66.6K | ﹤0.01% | 2714 |
|
|
2018
Q2 | $5.32M | Sell |
412,760
-16,464
| -4% | -$222K | ﹤0.01% | 2822 |
|
|
2018
Q1 | $5.34M | Buy |
429,224
+11,125
| +3% | +$135K | ﹤0.01% | 2765 |
|
|
2017
Q4 | $5.84M | Sell |
418,099
-31,882
| -7% | -$467K | ﹤0.01% | 2719 |
|
|
2017
Q3 | $7.56M | Buy |
449,981
+2,877
| +0.6% | +$46.8K | ﹤0.01% | 2582 |
|
|
2017
Q2 | $7.52M | Buy |
447,104
+49,274
| +12% | +$736K | ﹤0.01% | 2532 |
|
|
2017
Q1 | $6.16M | Buy |
397,830
+77,231
| +24% | +$1.1M | ﹤0.01% | 2601 |
|
|
2016
Q4 | $4.79M | Buy |
320,599
+58,340
| +22% | +$819K | ﹤0.01% | 2719 |
|
|
2016
Q3 | $3.3M | Buy |
262,259
+18,157
| +7% | +$182K | ﹤0.01% | 2782 |
|
|
2016
Q2 | $2.19M | Buy |
244,102
+8,915
| +4% | +$87.3K | ﹤0.01% | 2996 |
|
|
2016
Q1 | $2.33M | Buy |
235,187
+9,245
| +4% | +$94.8K | ﹤0.01% | 2945 |
|
|
2015
Q4 | $2.6M | Buy |
225,942
+8,892
| +4% | +$110K | ﹤0.01% | 2889 |
|
|
2015
Q3 | $2.93M | Buy |
217,050
+3,653
| +2% | +$49.5K | ﹤0.01% | 2816 |
|
|
2015
Q2 | $2.95M | Buy |
213,397
+2,877
| +1% | +$38.9K | ﹤0.01% | 2899 |
|
|
2015
Q1 | $2.96M | Buy |
210,520
+107,824
| +105% | +$1.47M | ﹤0.01% | 2852 |
|
|
2014
Q4 | $1.4M | Buy |
102,696
+5,426
| +6% | +$74.2K | ﹤0.01% | 3172 |
|
|
2014
Q3 | $1.49M | Buy |
97,270
+12,568
| +15% | +$192K | ﹤0.01% | 3136 |
|
|
2014
Q2 | $1.43M | Buy |
84,702
+10,575
| +14% | +$190K | ﹤0.01% | 3165 |
|
|
2014
Q1 | $1.49M | Buy |
74,127
+21,514
| +41% | +$465K | ﹤0.01% | 3166 |
|
|
2013
Q4 | $1.02M | Buy |
+52,613
| New | +$931K | ﹤0.01% | 3251 |
|
State Street's OXFD Position: Q1 2021 in Review
State Street sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 28,779 shares — an estimated $503K sold.
State Street first reported a position in OXFD in Q4 2013 and held it in 29 quarters. The position peaked at $7.58M in Q1 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- State Street reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- State Street sold 28,779 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $503K.
- State Street first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 29 quarters.
- State Street's Oxford Immunotec Global PLC Ordinary Shares position peaked at $7.58M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on State Street's 13F filing for Q1 2021, filed 17 May 2021.